Skip to content
value.today

Surefire Medical, Inc.

Total raised
$168 M
7 rounds on record
Latest round
$15 M
Oct 2022
First round on record
Apr 2011
Today
Private
No later event on record

Funding rounds

7 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Surefire Medical, Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Oct 2022$15 MNo. 7$10 to $50 million

Surefire Medical, Inc.: Raise no. 7, Oct 2022

Investors in this round

32 investors had bought by the notice of Nov 10, 2022: 32 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$15 M of $42 M offered; $27 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Colorado

People named in the notice

  • Mary T. Szela · Executive Officer, Director
  • Sean Murphy · Executive Officer, Director
  • Anil Singhal · Director
  • Diane Parks · Director
  • Gene McGrevin · Director
  • John L. Tullis · Director
  • Kerry Hicks · Director
  • Mats L. Wahlstrom · Director
  • Simone Song · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Mary Szela, President. Source: SEC Form D, newest notice filed Nov 10, 2022. Read the notice at the SEC.

equity, optionsSEC
Sep 2021$24 MNo. 6$10 to $50 million

Surefire Medical, Inc.: Raise no. 6, Sep 2021

Investors in this round

4 investors had bought by the notice of Nov 10, 2022: 4 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$24 M of $24 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Colorado

People named in the notice

  • Mary T. Szela · Executive Officer, Director
  • Raj L. Mistry · Executive Officer
  • Sean Murphy · Executive Officer, Director
  • Anil Singhal · Director
  • Diane Parks · Director
  • Gene McGrevin · Director
  • John L. Tullis · Director
  • Kerry Hicks · Director
  • Mats L. Wahlstrom · Director
  • Simone Song · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Mary Szela, President. Source: SEC Form D, newest notice filed Nov 10, 2022. Read the notice at the SEC.

equitySEC
Mar 2021$81 MNo. 5$50 to $250 million

Surefire Medical, Inc.: Raise no. 5, Mar 2021

Investors in this round

57 investors had bought by the notice of Nov 10, 2022: 57 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$81 M of $81 M offered
Smallest investment taken
no minimum stated
What was sold
equity, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Colorado

People named in the notice

  • Mary T. Szela · Executive Officer, Director
  • Raj L. Mistry · Executive Officer
  • Sean Murphy · Executive Officer, Director
  • Anil Singhal · Director
  • Diane Parks · Director
  • Gene McGrevin · Director
  • John L. Tullis · Director
  • Kerry Hicks · Director
  • Mats L. Wahlstrom · Director
  • Simone Song · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Mary Szela, President. Source: SEC Form D, newest notice filed Nov 10, 2022. Read the notice at the SEC.

equity, optionsSEC
Feb 2017$13 MNo. 4$10 to $50 million

Surefire Medical, Inc.: Raise no. 4, Feb 2017

Investors in this round

19 investors had bought by the notice of Mar 7, 2017: 19 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$13 M of $15 M offered; $2 M still to sell
Smallest investment taken
$1
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Anthony R. Scalese · Executive Officer
  • James E. Chomas · Executive Officer, Director
  • Beverly L. Huss · Director
  • Gene R. McGrevin · Director
  • Ginger L. Graham · Director
  • John R. Tullis · Director
  • Karen J. Cassidy · Director
  • Mats R. Wahlstrom · Director
  • Norman R. Weldon · Director
  • Simone R. Song · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by James E. Chomas, President and CEO. Source: SEC Form D, newest notice filed Mar 7, 2017. Read the notice at the SEC.

equitySEC
Jun 2015$15 MNo. 3$10 to $50 million

Surefire Medical, Inc.: Raise no. 3, Jun 2015

Investors in this round

54 investors had bought by the notice of Nov 5, 2015: 54 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$15 M of $15 M offered
Smallest investment taken
$1
What was sold
equity, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Bob J. Holburn · Executive Officer
  • James E. Chomas · Executive Officer, Director
  • Beverly L. Huss · Director
  • Gene R. McGrevin · Director
  • Ginger L. Graham · Director
  • John R. Tullis · Director
  • Karen J. Cassidy · Director
  • Norman R. Weldon · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by James E. Chomas, President and CEO. Source: SEC Form D and 1 amendment, newest notice filed Nov 5, 2015. Read the notice at the SEC.

equity, optionsSEC
Sep 2013$16 MNo. 2$10 to $50 million

Surefire Medical, Inc.: Raise no. 2, Sep 2013

Investors in this round

30 investors had bought by the notice of Sep 16, 2013: 30 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$16 M of $21 M offered; $5 M still to sell
Smallest investment taken
$1
What was sold
equity
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Aravind R. Arepally · Executive Officer
  • Bob J. Holburn · Executive Officer
  • James Chomas · Executive Officer, Director
  • Karen J. Cassidy · Executive Officer, Director
  • Norman R. Weldon · Executive Officer, Director
  • Gene R. McGrevin · Director
  • Ginger L. Graham · Director
  • Mark L. Lupa · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the amounts: “Total Offering Amount: $21,328,000.00 Total Amount Sold: $16,419,987.57 Total Remaining to be Sold: $4,908,012.43”

Signed by Bob Holburn, Vice President, CFO. Source: SEC Form D, newest notice filed Sep 16, 2013. Read the notice at the SEC.

equitySEC
Apr 2011$4 MNo. 1$2 to $10 million

Surefire Medical, Inc.: Raise no. 1, Apr 2011

Investors in this round

42 investors had bought by the notice of Apr 26, 2011: 42 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$4 M of $7 M offered; $3 M still to sell
Smallest investment taken
$1
What was sold
equity
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Aravind R. Arepally · Executive Officer
  • James Chomas · Executive Officer, Director
  • Karen J. Cassidy · Executive Officer, Director
  • Miles J. Gerson · Executive Officer
  • Norman R. Weldon · Executive Officer, Director
  • Ginger L. Graham · Director
  • Mark J. Lupa · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the amounts: “Total Offering Amount $6,732,000.00 Total Amount Sold $3,694,524.29 Total Remaining to be Sold $3,037,475.71”

Signed by James Chomas, President & Chief Executive Officer. Source: SEC Form D, newest notice filed Apr 26, 2011. Read the notice at the SEC.

equitySEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Surefire Medical, Inc. chose not to state its revenue in its newest notice of a funding round (Nov 2022).

    SEC Form D · Nov 2022

  • The industry group it chose in its notices: Other Health Care.

    SEC Form D · Nov 2022

That is all the official record says: Surefire Medical, Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of Surefire Medical, Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 7 rounds above had up to 57 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Surefire Medical, Inc.
NameRoleNamed in
Mary T. SzelaExecutive officerNov 2022
Raj L. MistryExecutive officerNov 2022
Sean MurphyExecutive officerNov 2022
Anthony R. ScaleseExecutive officerMar 2017
James E. ChomasExecutive officerMar 2017
Bob J. HolburnExecutive officerNov 2015
Aravind R. ArepallyExecutive officerSep 2013
James ChomasExecutive officerSep 2013
Karen J. CassidyExecutive officerSep 2013
Norman R. WeldonExecutive officerSep 2013
Miles J. GersonExecutive officerApr 2011
Anil SinghalDirectorNov 2022
Diane ParksDirectorNov 2022
Gene McGrevinDirectorNov 2022
John L. TullisDirectorNov 2022
Kerry HicksDirectorNov 2022
Mary T. SzelaDirectorNov 2022
Mats L. WahlstromDirectorNov 2022
Sean MurphyDirectorNov 2022
Simone SongDirectorNov 2022
Beverly L. HussDirectorMar 2017
Gene R. McGrevinDirectorMar 2017
Ginger L. GrahamDirectorMar 2017
James E. ChomasDirectorMar 2017
John R. TullisDirectorMar 2017
Karen J. CassidyDirectorMar 2017
Mats R. WahlstromDirectorMar 2017
Norman R. WeldonDirectorMar 2017
Simone R. SongDirectorMar 2017
James ChomasDirectorSep 2013
Mark L. LupaDirectorSep 2013
Mark J. LupaDirectorApr 2011